skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Saturday, February 12, 2011

Hangover Cure - Caffeine and Anti-Inflammatories

This just in.

Treat your hangover with caffeine and non-steroidal anti-inflammatory drugs, says this MSNBC news article, And the definitive hangover cure is ... plain old coffee and aspirin, actually.

Return Home: http://drughealth.blogspot.com/



Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 10:39 AM
Labels: Anti-inflammatory, caffeine, coffee, cure, drug, hangover, headache, health, Non-steroidal anti-inflammatory drug, nsaid, otc, prescription, treatment

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

  • Popular cGMP Online Training Courses Updated
  • As Supply Chain Partners Ramp Up For November DSCSA Deadline, US FDA Gives Them Another Year - Pink Sheet
  • California Designated Representative 3PL Training Course
  • DRUG FRAUD ALERT: DISTRIBUTOR/CUSTOMER PRODUCT ORDERING SCHEME
  • Drug Products, Including Biological Products, that Contain Nanomaterials - Final Guidance Document
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • Medscape Today Headlines
    Gene Therapy: Medical Progress Has a Price, Says Ethicist
    40 minutes ago
  • FierceBiotech
    Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab
    1 hour ago
  • FiercePharma
    FDA's new commissioner Marty Makary signed off on Peter Marks ouster: Politico
    1 hour ago
  • eLearning Industry
    Top 6 Soft Skills To Master In 2025 With Your Corporate LMS
    2 hours ago
  • CNBC Health Care
    Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
    2 hours ago
  • GEN Biotech News
    Ultima Genomics Gives Away Sequencing for Free. Literally.
    3 hours ago
  • Clarkston Consulting
    2025 Diagnostics Trends
    3 hours ago
  • BioPharma Dive - Latest News
    RNA editing biotech Airna adds $155M in funding
    4 hours ago
  • Drug Channels
    The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars (rerun)
    4 hours ago
  • Drug & Device Law
    District of New Jersey Shuts Down Abusive Discovery in Allergan Biocell MDL
    5 hours ago
  • Wellness Blog - NY Times
    ‘White Lotus’ Highlights the Way Old Friends Bring Out Our Worst Selves
    6 hours ago
  • All Kaiser Health News
    Trump Says He’ll Stop Health Care Fraudsters. Last Time, He Let Them Walk.
    6 hours ago
  • Science-Based Medicine
    The tragic termination of the Diabetes Prevention Program Outcomes Study
    7 hours ago
  • Medtech Insight
    Exact Sciences Launches Cologuard Plus
    8 hours ago
  • Pharmaceutical Commerce
    Revolutionizing Pharma Patient Assistance Programs, KnippeRx Leads the Future of Patient Care
    11 hours ago
  • Government Executive
    Trump administration, unions already trading lawsuits over order outlawing most government labor groups
    17 hours ago
  • BioPharma Dive
    Trump administration to shut down CMS, HHS minority health offices amid restructuring
    17 hours ago
  • Healthcare Packaging
    The Rise in Temperature-Controlled Pharmaceuticals
    19 hours ago
  • Mobihealthnews
    Isomorphic Labs secures $600M in funding for AI drug design
    21 hours ago
  • FierceBiotech: Medtech
    GE HealthCare unveils cardiac-focused CT scanner, launches coronary radiotracer
    21 hours ago
  • Quality Matters
    The enduring impact of the USP Convention
    22 hours ago
  • FDA What's New: Drugs
    October - December 2024 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
    23 hours ago
  • Pharmafile
    Qfitlia approved by FDA to treat haemophilia A or B
    23 hours ago
  • Pharmafile - Mfg & Production
    Alfred Merz appointed as CEO of ProBioGen
    1 day ago
  • Pharmalot – STAT
    STAT+: Pharmalittle: We’re reading about fallout over ousted FDA official, a Colorado pharma setback, and more
    1 day ago
  • Modern Healthcare News
    Healthcare sector shaken as Trump stirs havoc in D.C.
    1 day ago
  • NPR Blogs: Shots - Health News Blog
    How much will that surgery cost? Hospital price lists remain largely unhelpful
    1 day ago
  • JD Supra Law News
    Key Takeaways From the Copyright Office's Report on the Economic Impact of AI
    3 days ago
  • FDA - Press Releases
    FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
    3 days ago
  • World Pharma - Breaking News
    Preclinical study: after heart attack, a boost in anti-inflammatory cells promoted healing
    4 days ago
  • Clinical Correlations
    A Brief History of Insulin and Type 1 Diabetes
    1 week ago
  • The Incidental Economist
    An Opportunity: Philanthropy Can Reshape Drug Innovation
    1 week ago
  • Marler Blog
    FDA again kicks the Food Traceability Rule down the Road
    1 week ago
  • Food Poison Journal
    Salmonella Outbreak tied to Pastries over
    1 week ago
  • Asbestos and Mesothelioma News
    From Toxic Pile to Carbon Sponge: Asbestos Mine Gets a Green Makeover
    1 week ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    3 weeks ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    5 weeks ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    2 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    2 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    2 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    2 months ago
  • Designated Representative and Exemptee
    Exemptee Training | Designated Representative Training
    2 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    3 months ago
  • The Compliance and Ethics Blog
    Bob Wade on Fair Market Value in Healthcare [Podcast]
    6 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    6 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Combined vaping & smoking increases lung cancer risk
    7 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    8 months ago
  • SkillsPlus International Info
    Popular cGMP Online Training Courses Updated
    8 months ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    1 year ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    1 year ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Ted Eytan, MD
    Recipe: Keto Peanut Butter Pie
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    2 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    2 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ▼  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ▼  February (10)
      • FDA To Outsource Overseas Inspections
      • Clinical Study Of Disulfiram To Reduce HIV Reservoir
      • Battle Common Cold With Zinc
      • Drug Thieves Target Pharmacies
      • FDA - New Process Validation Guidance Document
      • If You're Anti-Vaccination - Then Risk Deafness, B...
      • Hangover Cure - Caffeine and Anti-Inflammatories
      • Preventive Anti-HIV Drug Use - Cautious Prescribing
      • FDA - 21 CFR 820 - Mobile Optimized
      • Icky Flu Spewers
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo